AI-Powered diet plan could revolutionize healthy eating
NCT ID NCT07638241
First seen Jun 27, 2026 · Last updated Sep 16, 2026 · Updated 2 times
Summary
This study tests whether an AI-based system that gives personalized diet advice can help people eat better and improve their metabolic health. Two hundred adults who had a health checkup will be split into three groups: one gets a fixed diet plan from AI, another gets a plan that adapts based on their progress, and a control group gets standard advice. The trial lasts 12 weeks and measures changes in diet quality, body mass index, and waist size.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- AI-based personalized dietary management algorithm
- What this could lead to
- If successful, this could lead to a practical, AI-driven tool that helps people improve their eating habits and reduce metabolic risks like obesity and high blood pressure.
- What could go wrong
- This is a small, early-stage trial (200 people) testing a behavioral intervention, not a drug. The AI tool may not work for everyone, and long-term benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2026
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 90 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Adults aged 20 years or older * Individuals from the general population who underwent a health examination at the Seoul National University Hospital Healthcare System Gangnam Center * Individuals who are capable of independently using a smartphone and operating study-related applications or text messaging functions * Individuals without conditions that significantly interfere with standard dietary management, as specified in the exclusion criteria \[Section 9.2 Exclusion Criteria\] Exclusion Criteria: * Individuals unable to use a smartphone or study-related digital program/application, including those without a smartphone or unable to operate text messaging or application-based functions. * End-stage renal disease or patients currently receiving dialysis * Active cancer or currently undergoing chemotherapy or radiotherapy * Severe heart failure, liver cirrhosis, or hepatic insufficiency accompanied by varices, bleeding, ascites, hepatic encephalopathy, or jaundice * Malabsorption disorders such as Crohn's disease or short bowel syndrome * Poorly controlled hyperthyroidism or hypothyroidism * Diagnosed eating disorders or severe psychiatric disorders * Pregnant or breastfeeding women, or women who may become pregnant during study participation. * Individuals with recent major weight-related interventions or extreme body weight changes within the past 3 months, including:Bariatric surgery such as gastrectomy or gastric bypass surgery Newly initiated anti-obesity pharmacotherapy (e.g., semaglutide/Wegovy, tirzepatide/Mounjaro) * Individuals considered by the investigator to have poor compliance potential or otherwise deemed unsuitable for participation in the clinical study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Dietary behavior; metabolic health; obesity; lifestyle modification; metabolic syndrome risk are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Seoul National University Hospital Healthcare System Gangnam Center
RECRUITINGSeoul, Seoul, 06236, South Korea